Transcript • Nov. 3, 2025 1:30 PM • Bruker Corporation (BRKR)
Transcript
Nov. 3, 2025 1:30 PM
Bruker Corporation (BRKR)
Unknown: Revenue-wise, it's been a little weaker, and we expect that to improve next year. So SEMI really has to look at it on an annual level, and it's a very nice margin contributor. SEMI now is approaching or is around $300 million in annual revenue, so it's also pretty meaningful for us. And it's very, along with the diagnostics business, has some of the best incremental margins. So those are very cool.
